National Comprehensive Cancer Network

National Comprehensive Cancer Network National Comprehensive Cancer Network is a not-for-profit alliance of 34 leading cancer centers.

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of leading cancer centers is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care

delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives

The NCCN Member Institutions are:
Abramson Cancer Center at the University of Pennsylvania
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
City of Hope National Medical Center
Dana-Farber/Brigham and Women’s Cancer Center | Mass General Cancer Center
Duke Cancer Institute
Fox Chase Cancer Center
Fred & Pamela Buffett Cancer Center
Fred Hutchinson Cancer Center
Huntsman Cancer Institute at the University of Utah
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
John Hopkins Kimmel Cancer Center
Mayo Clinic Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Moffitt Cancer Center
O'Neal Comprehensive Cancer Center at UAB
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Roswell Park Comprehensive Cancer Center
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center
Stanford Cancer Institute
The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute
The UChicago Medicine Comprehensive Cancer Center
The University of Texas MD Anderson Cancer Center
UC Davis Comprehensive Cancer Center
UC San Diego Moores Cancer Center
UCLA Jonsson Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center
University of Colorado Cancer Center
University of Michigan Rogel Cancer Center
University of Wisconsin Carbone Cancer Center
UT Southwestern Simmons Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Yale Cancer Center/Smilow Cancer Hospital

The   Oncology Fellows Program recordings are now available! Explore practical strategies for transitioning into oncolog...
07/29/2026

The Oncology Fellows Program recordings are now available! Explore practical strategies for transitioning into oncology practice, delivering high-quality care across diverse practice settings, engaging responsibly on social media, and more. Access the recordings and earn CE: https://education.nccn.org/fellows-program

Join us on September 18 - 19 in New York City or virtually for the NCCN 2026 Annual Congress: Hematologic Malignancies. ...
07/27/2026

Join us on September 18 - 19 in New York City or virtually for the NCCN 2026 Annual Congress: Hematologic Malignancies. Hear from Kateryna Fedorov, MD, of Vanderbilt-Ingram Cancer Center as she discusses oral targeted therapies for relapsed/refractory acute myeloid leukemia. Register now: https://bit.ly/Hem2026

We send our sincere gratitude to those who attended the NCCN 2026 Annual Conference, and we are excited to invite the en...
07/22/2026

We send our sincere gratitude to those who attended the NCCN 2026 Annual Conference, and we are excited to invite the entire oncology community to the 2027 Annual Conference happening March 19-21, 2027 in San Diego, CA and virtually.

We send our sincere gratitude to those who attended the NCCN 2026 A...

View previous NCCN Oncology Policy Webinars focusing on Innovations in Cancer Care Through the Ages and Health Literacy ...
07/21/2026

View previous NCCN Oncology Policy Webinars focusing on Innovations in Cancer Care Through the Ages and Health Literacy in the Cancer Care Digital Age.
Learn more and view now:

View previous NCCN Oncology Policy Webinars. Visit https://www.nccn.org/summits for upcoming events and webinars.

Publication of standardized terminology for biomarker testing in JNCCN marks an important step towards building consensu...
07/20/2026

Publication of standardized terminology for biomarker testing in JNCCN marks an important step towards building consensus and a common language around this complex and important topic.
Results of biomarker testing significantly impact patient management, prognosis, and therapy selection in oncology. Standardized biomarker testing terminology aids accurate exchange of information and will help to ensure that biomarker testing is guideline concordant so that patients receive the right treatment at the right time. Read more:
https://jnccn.org/view/journals/jnccn/aop/article-10.6004-jnccn.2026.7021/article-10.6004-jnccn.2026.7021.xml

07/16/2026

Only a few days left to enjoy the best rates for the NCCN 2026 Annual Congress: Hematologic Malignancies! Join us on September 18 – 19 to learn the latest oncology updates with curated sessions, earn CE/MOC credits, and more. Early bird discount ends July 20: https://bit.ly/Hem2026

Join us in New York City this fall for the Hematologic Malignancies Congress. Hear from experts, including MiKaela M. Ol...
07/13/2026

Join us in New York City this fall for the Hematologic Malignancies Congress. Hear from experts, including MiKaela M. Olsen, DNP, APRN-CNS, AOCNS, FAAN, and Grace Pak, PharmD, MHA, BCPS, from Johns Hopkins Medicine as they discuss optimizing small-volume drug delivery and more.
Register now: https://bit.ly/Hem2026

The Call for Abstracts for the NCCN 2027 General Poster Session is now open! NCCN welcomes original abstracts from all i...
07/09/2026

The Call for Abstracts for the NCCN 2027 General Poster Session is now open! NCCN welcomes original abstracts from all investigators in the general oncology community, including physicians, researchers, graduate students, fellows, nurses, advanced practice clinicians, allied health professionals, advocacy groups, and industry. Submit by October 21: NCCN.org/conference

Address

3025 Chemical Road, Suite 100
Plymouth Meeting, PA
19462

Alerts

Be the first to know and let us send you an email when National Comprehensive Cancer Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to National Comprehensive Cancer Network:

Share